Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$669,376.00
Apr 1, 2024
Individual or sole proprietorship
Project Grant
175375
The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.
$581,398.00
Apr 1, 2024
Individual or sole proprietorship
Project Grant
175034
The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.
$707,625.00
Apr 1, 2024
Individual or sole proprietorship
Project Grant
175177
The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.
$1,158,975.00
Apr 1, 2024
Individual or sole proprietorship
Project Grant
175132
The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.
$750,000.00
Apr 1, 2024
Individual or sole proprietorship
Op Gr.: Eval. of Dementia Programs, Services, & Care Models - Stream 1 - General
178636
The specific objectives of this funding opportunity are to:
• Strengthen integration, uptake, deployment and/or scale-up (spread) of evidence-based solutions: Improve existing programs, services, and/or models of care including equitable and inclusive access for diverse groups of people living with cognitive impairment and dementia, and for those that care for them.
• Build capacity: Strengthen implementation science approaches informed by intersectional equity, diversity and inclusion (EDI) considerations among research teams, including early career researchers and knowledge users (i.e., PWLLE, decision makers), in cognitive impairment research.
• Spark interdisciplinary collaborations: Build partnerships and collaborations across sectors and jurisdictions, as appropriate, to co-develop and implement projects to contribute to a sustained and equitable impact beyond the duration of the grant.
• Foster knowledge mobilization and impact: Foster patient-oriented and integrated knowledge mobilization approaches and strategies throughout the research process to inform timely uptake and maximize research relevance and impact.
$20,000.00
Apr 1, 2024
Individual or sole proprietorship
Team Grant: Embracing Diversity to Achieve Precision & Health Equity-Aging - LOI
178569
Funding Pool of EDL; related codes EL0-EL9
The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:
- Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
- Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
- Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease
Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.
$19,936.00
Apr 1, 2024
Individual or sole proprietorship
T. Gr.: Embracing Diversity -HIV/AIDS/STBBI-Co-infections and Co-morbidities-LOI
178579
The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:
- Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
- Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
- Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease
Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.
$19,690.00
Apr 1, 2024
Individual or sole proprietorship
T. Gr.: Embracing Diversity -HIV/AIDS/STBBI-Co-infections and Co-morbidities-LOI
178581
The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:
- Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
- Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
- Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease
Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.
$20,000.00
Apr 1, 2024
Individual or sole proprietorship
Tm Gr.: Emb. Diversity to Achieve Prec./Health Eq-Nutrition/Metabolic Health-LOI
178595
The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:
- Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
- Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
- Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease
Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.
$712,667.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177575
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.